Frontiers in inflammatory bowel disease.  The proceedings of a conference sponsored by the McReynolds Foundation.  Part II.
D000230:Adenocarcinoma / Q000209:etiology; D001168:Arthritis / Q000209:etiology; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002908:Chronic Disease; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy; D003110:Colonic Neoplasms / Q000209:etiology; D003348:Cortisone / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D004751:Enteritis / Q000150:complications / Q000188:drug therapy; D005500:Follow-Up Studies; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D007414:Intestinal Neoplasms / Q000209:etiology; D007421:Intestine, Small; D008107:Liver Diseases / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D013167:Spondylitis, Ankylosing / Q000209:etiology
D001379:Azathioprine; D003348:Cortisone; D011241:Prednisone